Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research

5142 - Thermal Liquid Biopsy as a new tool for Lung Cancer patients diagnostic: pilot study

Date

20 Oct 2018

Session

Poster display session: Biomarkers, Gynaecological cancers, Haematological malignancies, Immunotherapy of cancer, New diagnostic tools, NSCLC - early stage, locally advanced & metastatic, SCLC, Thoracic malignancies, Translational research

Presenters

Alberto Rodrigo Cáceres

Citation

Annals of Oncology (2018) 29 (suppl_8): viii479-viii482. 10.1093/annonc/mdy294

Authors

A. Rodrigo Cáceres1, O. Abian2, A. Velazquez-Campoy3, A. Callejo4, S. Vega5, A. Fernandez6, O. Sánchez-Gracia2, P. Iranzo Gomez6, M. Cruellas6, E. Quilez Bielsa6, D. Isla6

Author affiliations

  • 1 Medical Oncology, Hospital Arnau de Vilanova, 25198 - Lleida/ES
  • 2 Research, IACS-ISS Aragón, Zaragoza/ES
  • 3 Research, ARAID Foundation, Zaragoza/ES
  • 4 Oncology Department, Hospital de la Santa Creu i Sant Pau, 8026 - Barcelona/ES
  • 5 Research, BIFI institute-University of Zaragoza, Zaragoza/ES
  • 6 Medical Oncology, Hospital Clinico Universitario Lozano Blesa, 50009 - Zaragoza/ES
More

Resources

Abstract 5142

Background

Thermal Liquid Biopsy (TLB) is based on Differential Scanning Calorimetry (DSC, calorimetric thermogram analysis of serum samples) as a new clinical approach for diagnostic assessment of lung cancer patients. DSC is highly sensitive and it studies the unfolding transitions in proteins by thermal denaturation. The DSC profile of blood serum has been previously proposed as a novel approach for diagnosis and monitoring several diseases. Our main objective is to determine the TLB capacity to differentiate between Healthy Controls (HC) and Lung Cancer Patients (LCP).

Methods

Blood samples from HC and LCP were analyzed with a high sensitivity microcalorimeter VP-DSC (MicroCal-Malvern). The data were processed by Origin 7 software. Thermograms acquired were analyzed with a multiparametric method developed by our research group, procuring some indicators to interpret the results. The Area Under the Curve (AUC) was analyzed and the Youden’s Index obtained from ROC curves, allowing to construct the contingency tables. Odds Ratio (OR) was also calculated by binary logistic regression.

Results

117 samples from LCP (Average age 64.6±8.7, 83.0% men) stage distribution (II: 5.2%, III: 25.9%; IV: 69.0%), smoking status (63.8% smoking, 6.5% non-smoking) histology distribution (37.1% Adenocarcinoma, 28.4% Squamous, 30.2% small cell) compared to 123 HC from a blood bank with homogeneous distribution. 10 out of 28 parameters of our multiparametric method showed statistical differences between HC and LCP. After developing ROC curves, AUC higher than 0.75 were observed in these 10 parameters, exceeding 0.85 in 3 of them. The Youden’s index was calculated for all, finding sensitivity and specificity values higher than 75.0-90.0% (for the best parameter both were more than 85.0%). Comparing HC to LCP, we calculated OR obtaining 10 parameters over 10, showing a high positive association between clinical parameters and DSC results.

Conclusions

High positive association between clinical groups and TLB parameters offers advantages over current diagnosis techniques (CT imaging), providing a powerful diagnostic approach with a minimally-invasive, low-risk, low-cost clinical test for LCP. Future promising applications, such as screening programs, could be developed from TLB.

Clinical trial identification

Legal entity responsible for the study

Instituto Investigación Sanitaria de Aragón (ISS).

Funding

Institute Carlos III (Spain).

Editorial Acknowledgement

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.